Molecular Genetics of Mycobacteria ASM Press Washington DC 2000, 235–253. 14. Williams CDK activation DL, Spring L, Collins L, Miller LP, Heifets
LB, Gangadharam PR, Gillis TP: Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 1998, 42:1853–57.PubMed 15. Augustynowicz-Kopec E, Zwolska Z, Jaworski A, Kostrzewa E, Klatt M: Drug resistant tuberculosis in Poland in 2000: second national survey and comparison with the 1997 survey. Int J Tuberc Lung Dis 2003, 7:1–7. 16. Sambrook J, Russel DW: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press 2001. 17. Collins LA, Franzblau SG: Microplate Alamar Blue Assay versus BACTEC 460 system for hight-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob Agents Chemother 1997, 41:1004–09.PubMed 18. Franzblau SG, Witzig RS, McLaughlin JC, Torres P, Madico G, Hernandez A, Degnan MT, Cook MB, Quenzer VK, Ferguson RM, Gilman RH: Rapid,
low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the Microplate Alamar Blue Assay. J Clin Microbiol 1998, 36:362–6.PubMed 19. Reis RS, Neves I Jr, Entospletinib ic50 Lourenco SLS, Fonseca LS, Lourenco MCS: Comparison of Flow Cytometric and Alamar Blue Test with the Proportional Method for testing susceptibility of Mycobacterium tuberculosis to rifampin and isoniazid. J Clin Microbiol 2004, 42:2247–48.CrossRefPubMed 20. Taniguchi H, Aramaki H, Nikaido Y, Mizuguchi Y, Nakamura M, Koga T, Yoshida S: Rifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis. FEMS Microbiol Letters 1996, 144:103–08.CrossRef 21. Yang B, Koga H, Ohno H, Ogawa K, Fukuda M, Hirakata Y, Maesaki S, Tomono K, Tashiro T, Kohno S: Detection between antimicrobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis. J Antimicrob Chemother 1998, 42:621–28.CrossRefPubMed 22. Chan RCY, Hui M, Chan EWC, Au TK, Chin ML, Yip CK, AuYeang CKW, Yeung CYL, Kam KM, Yip PCW, Cheng AFB: Genetic and phenotypic characterization of drug-resistant
Mycobacterium tuberculosis isolates in Hong Kong. J Antimicrob Chemother 2007, 59:866–73.CrossRefPubMed Baricitinib 23. Huitric E, Werngren J, Jureen P, Hoffner S: Resistance levels and rpoB gene mutations among in vitro-selected rifampin-resistant Mycobacterium tuberculosis mutants. Antimicrob Agents Chemother 2006, 50:2860–62.CrossRefPubMed 24. Dziadek J, Madiraju MVVS, Rutherford SA, Atkinson MAL, Rajagopalan M: Physiological consequences associated with overproduction of Mycobacterium tuberculosis FtsZ in mycobacterial hosts. Microbiology 2002, 148:961–71.PubMed 25. Brzostek A, Sliwinski T, Rumijowska-Galewicz A, Korycka-Machala M, Dziadek J: Identification and targeted disruption of the gene encoding the main 3-ketosteroid dehydrogenase in Mycobacterium smegmatis. Microbiology 2005, 151:2393–2402.CrossRefPubMed 26.